XYOSTED (AUTOINJECTOR) Drug Patent Profile

✉ Email this page to a colleague

When do Xyosted (autoinjector) patents expire, and what generic alternatives are available?

Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are twenty-three patents protecting this drug.

This drug has ninety-seven patent family members in fourteen countries.

The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Xyosted (autoinjector)

A generic version of XYOSTED (AUTOINJECTOR) was approved as testosterone enanthate by NEXUS on June 14^th, 2006.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for XYOSTED (AUTOINJECTOR)?
What are the global sales for XYOSTED (AUTOINJECTOR)?
What is Average Wholesale Price for XYOSTED (AUTOINJECTOR)?

Summary for XYOSTED (AUTOINJECTOR)

International Patents:	97
US Patents:	23
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	55
Patent Applications:	2,630
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for XYOSTED (AUTOINJECTOR)
DailyMed Link:	XYOSTED (AUTOINJECTOR) at DailyMed

Drug patent expirations by year for XYOSTED (AUTOINJECTOR)

Pharmacology for XYOSTED (AUTOINJECTOR)

Drug Class	Androgen
Mechanism of Action	Androgen Receptor Agonists

US Patents and Regulatory Information for XYOSTED (AUTOINJECTOR)

XYOSTED (AUTOINJECTOR) is protected by twenty-three US patents.

Patents protecting XYOSTED (AUTOINJECTOR)

Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Injection device with cammed RAM assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Prefilled syringe injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Testosterone ester triglyceride formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Needle assisted injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Needle assisted injection administration of testosterone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Hematocrit modulation through needle assisted jet injection of testosterone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Syringe shock absorber for use in an injection device
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Prefilled syringe injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for XYOSTED (AUTOINJECTOR)

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018	⤷ Sign Up	⤷ Sign Up
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018	⤷ Sign Up	⤷ Sign Up
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-001	Sep 28, 2018	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for XYOSTED (AUTOINJECTOR)

See the table below for patents covering XYOSTED (AUTOINJECTOR) around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	3675868		⤷ Sign Up
World Intellectual Property Organization (WIPO)	2006079064		⤷ Sign Up
Hungary	E042286		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for XYOSTED (AUTOINJECTOR)

Pharmacology for XYOSTED (AUTOINJECTOR)

Patents protecting XYOSTED (AUTOINJECTOR)

Make Better Decisions: Try a trial or see plans & pricing